Cloning and functional characterization of the HRASLS2 gene

Amino Acids

Volumn 35, Issue 1, 2008, Pages 129-137

  Shyu, R Y ^a   Hsieh, Y C ^a,b   Tsai, F M ^a   Wu, C C ^c   Jiang, S Y ^a,b  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^c TRI SERVICE GENERAL HOSPITAL   (Taiwan)

Author keywords

Apoptosis; Growth suppression; HRASLS2; HRASLS3; RARRES3; RAS; Tumor suppressor gene

Indexed keywords

COMPLEMENTARY DNA;

ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE; GENE EXPRESSION; GENE FUNCTION; GENE SEQUENCE; HELA CELL; HRASLS2 GENE; HUMAN; HUMAN CELL; MOLECULAR CLONING; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

CELL DIFFERENTIATION; CLONING, MOLECULAR; GENE EXPRESSION REGULATION, NEOPLASTIC; HELA CELLS; HL-60 CELLS; HUMANS; ORGAN SPECIFICITY; PROTEIN STRUCTURE, TERTIARY; TUMOR SUPPRESSOR PROTEINS;

EID: 44949109348     PISSN: 09394451     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00726-007-0612-2     Document Type: Article

References (26)

1. Akiyama H, Hiraki Y, Noda M, Shigeno C, Ito H, Nakamura T (1999) Molecular cloning and biological activity of a novel Ha-Ras suppressor gene predominantly expressed in skeletal muscle, heart, brain, and bone marrow by differential display using clonal mouse EC cells, ATDC5. J Biol Chem 274: 32192-32197
2. Anantharaman V, Aravind L (2003) Evolutionary history, structural features and biochemical diversity of the NlpC/P60 superfamily of enzymes. Genome Biol 4: R11
3. Deucher A, Nagpal S, Chandraratna RA, Di Sepio D, Robinson NA, Dashti SR, Eckert RL (2000) The carboxy-terminal hydrophobic domain of TIG3, a class II tumor suppressor protein, is required for appropriate cellular localization and optimal biological activity. Int J Oncol 17: 1195-1203
4. DiSepio D, Ghosn C, Eckert RL, Deucher A, Robinson N, Duvic M, Chandraratna RA, Nagpal S (1998) Identification and characterization of a retinoid-induced class II tumor suppressor/growth regulatory gene. Proc Natl Acad Sci USA 95: 14811-14815
5. Duvic M, Helekar B, Schulz C, Cho M, Jackson B, Breuer-McHam J, Young J, Clayman G, Lippman SM, DiSepio D, Hager C, DiMao D, Hazarika P, Chandraratna RA, Robinson NA, Deucher A, Eckert RL, Nagpal S (2000) Expression of a retinoid-inducible tumor suppressor, Tazarotene-inducible gene-3, is decreased in psoriasis and skin cancer. Clin Cancer Res 6: 3249-3259
6. Hajnal A, Klemenz R, Schafer R (1994) Subtraction cloning of H-rev107, a gene specifically expressed in H-ras resistant fibroblasts. Oncogene 9: 479-490
7. Higuchi E, Chandraratna RA, Hong WK, Lotan R (2003) Induction of TIG3, a putative class II tumor suppressor gene, by retinoic acid in head and neck and lung carcinoma cells and its association with suppression of the transformed phenotype. Oncogene 22: 4627-4635
8. Huang SL, Shyu RY, Yeh MY, Jiang SY (2000) Cloning and characterization of a novel retinoid-inducible gene 1(RIG1) deriving from human gastric cancer cells. Mol Cell Endocrinol 159: 15-24
9. Huang SL, Shyu RY, Yeh MY, Jiang SY (2002) The retinoid-inducible gene I: effect on apoptosis and mitogen-activated kinase signal pathways. Anticancer Res 22: 799-804
10. Hughes PJ, Stanway G (2000) The 2A proteins of three diverse picornaviruses are related to each other and to the H-rev107 family of proteins involved in the control of cell proliferation. J Gen Virol 81: 201-207
11. Husmann K, Sers C, Fietze E, Mincheva A, Lichter P, Schafter R (1998) Transcriptional and translational downregulation of H-REV107, a class II tumour suppressor gene located on human chromosome 11q11-12. Oncogene 17: 1305-1312
12. Ito H, Akiyama H, Shigeno C, Nakamura T (2001) Isolation, characterization, and chromosome mapping of a human A-C1 Ha-Ras suppressor gene (HRASLS). Cytogenet Cell Genet 93: 36-39
13. Kaneda A, Kaminishi M, Yanagihara K, Sugimura T, Ushijima T (2002) Identification of silencing of nine genes in human gastric cancers. Cancer Res 62: 6645-6650
14. Lenburg ME, Liou LS, Gerry NP, Frampton GM, Cohen HT, Christman MF (2003) Previously unidentified changes in renal cell carcinoma gene expression identified by parametric analysis of microarray data BMC. Cancer 3: 31
15. Lotz K, Kellner T, Heitmann M, Nazarenko I, Noske A, Malek A, Gontarewicz A, Schafer R, Sers C (2005) Suppression of the TIG3 tumor suppressor gene in human ovarian carcinomas is mediated via mitogen-activated kinase-dependent and -independent mechanisms. Int J Cancer 116: 894-902
16. Marchler-Bauer A, Anderson JB, Cherukuri PF, DeWeese-Scott C, Geer LY, Gwadz M, He S, Hurwitz DI, Jackson JD, Ke Z, Lanczycki CJ, Liebert CA, Liu C, Lu F, Marchler GH, Mullokandov M, Shoemaker BA, Simonyan V, Song JS, Thiessen PA, Yamashita RA, Yin JJ, Zhang D, Bryant SH (2005) CDD: a conserved domain database for protein classification. Nucleic Acids Res 33: D192-D196
17. Nazarenko I, Schafer R, Sers C (2007) Mechanisms of the HRSL3 tumor suppressor function in ovarian carcinomacells. JCell Sci 120: 1393-1404
18. Sers C, Emmenegger U, Husmann K, Bucher K, Andres AC, Schafer R (1997) Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. J Cell Biol 136: 935-944
19. Sers C, Husmann K, Nazarenko I, Reich S, Wiechen K, Zhumabayeva B, Adhikari P, Schroder K, Gontarewicz A, Schafer R (2002) The class II tumour suppressor gene H-REV107-1 is a target of interferon-regulatory factor-1 and is involved in IFNgamma-induced cell death in human ovarian carcinoma cells. Oncogene 21: 2829-2839
20. Shyu RY, Jiang SY, Chou JM, Shih YL, Lee MS, Yu JC, Chao PC, Hsu YJ, Jao SW (2003) RARRES3 expression positively correlated to tumour differentiation in tissues of colorectal adenocarcinoma. Br J Cancer 89: 146-151
21. Siegrist S, Feral C, Chami M, Solhonne B, Mattei MG, Rajpert-De Meyts E, Guellaen G, Bulle F (2001) hH-Rev107, a class II tumor suppressor gene, is expressed by post-meiotic testicular germ cells and CIS cells but not by human testicular germ cell tumors. Oncogene 20: 5155-5163
22. Simmons DP, Peach ML, Friedman JR, Green MM, Nicklaus MC, De Luca LM (2006) Evidence that sequence homologous region in LRAT-like proteins possesses anti-proliferative activity and DNA binding properties: translational implications and mechanism of action. Carcinogenesiss 27: 693-707
23. Sturniolo MT, Chandraratna RA, Eckert RL (2005) A novel transglutaminase activator forms a complex with type 1 transglutaminase. Oncogene 24: 2963-2972
24. Sturniolo MT, Dashti SR, Deucher A, Rorke EA, Broome AM, Chandraratna RA, Keepers T, Eckert RL (2003) A novel tumor suppressor protein promotes keratinocyte terminal differentiation via activation of type I transglutaminase. J Biol Chem 278: 48066-48073
25. Tsai FM, Shyu RY, Jiang SY (2006) RIG1 inhibits the Ras/mitogen-activated protein kinase pathway by suppressing the activation of Ras. Cell Signal 18: 349-358
26. Tsai FM, Shyu RY, Jiang SY (2007) RIG1 suppresses Ras activation and induces cellular apoptosis at the Golgi apparatus. Cell Signal 19: 989-999